Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release

被引:161
作者
Tran, Phuong Ha Lien [1 ]
Tran, Huyen Thi Thanh [1 ]
Lee, Beom-Jin [1 ]
机构
[1] Kangwon Natl Univ, Coll Pharm, Natl Res Lab Bioavailabil Control, Chunchon, South Korea
关键词
telmisartan; solid dispersion; alkalizers; dissolution rate; structural behavior; pH modulation;
D O I
10.1016/j.jconrel.2008.04.001
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The present work is an original evaluation of the microenvironmental pH (pH(M)) and crystallinity of an ionizable drug in order to enhance its dissolution using alkalizers in polyethylene glycol 6000 (PEG 6000) based solid dispersions (SDs). Telmisartan (TEL) was chosen as a model drug due to its poor and pH-dependent water solubility. The nine alkalizers used to modify the pH of TEL were MgO, NaOH, KOH, Na2CO3, NaHCO3, bentonite, Na2HPO4, K2HPO4 and arginine. MgO, NaOH, KOH and Na2CO3 in the SD system significantly increased the drug dissolution rate in intestinal fluid (pH 6.8) and water. Modulation of pH(M) was clearly observed as a function of time at different fractional dimensions of tablet. Structural change in drug crystallinity to an amorphous form was also a contributing factor based on differential scanning calorimetry (DSC) thermograms and powder X-ray diffraction (PXRD) patterns. The drug frequency of the C=O band decreased and the C-H broad band in the Fourier transform infrared (FTIR) spectra disappeared when these alkalizers were added. It was evident that the alkalizers in PEG 6000 based SDs synergistically enhanced dissolution of TEL not only by modulating pH(M) but also by changing drug crystallinity to an amorphous form via molecular interactions. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 19 条
[1]   Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers [J].
Ahuja, Naveen ;
Katare, Om Prakash ;
Singh, Bhupinder .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 65 (01) :26-38
[2]   pKa determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry [J].
Cagigal, E ;
González, L ;
Alonso, RM ;
Jiménez, RM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (03) :477-486
[3]   MICROENVIRONMENTAL PH CONTROL OF DRUG DISSOLUTION [J].
DOHERTY, C ;
YORK, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 50 (03) :223-232
[4]   Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole [J].
Heo, MY ;
Piao, ZZ ;
Kim, TW ;
Cao, QR ;
Kim, A ;
Lee, BJ .
ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (05) :604-611
[5]   Role of hydrogen bonding interactions in directing one-dimensional thiol-assisted growth of silver-based nanofibers [J].
Hernandez, EA ;
Posada, B ;
Irizarry, R ;
Castro, ME .
JOURNAL OF PHYSICAL CHEMISTRY B, 2005, 109 (15) :7251-7257
[6]   Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems [J].
Hu, JH ;
Johnston, KP ;
Williams, RO .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 20 (03) :295-303
[7]  
Kalaiselvan R., 2006, Indian Journal of Pharmaceutical Sciences, V68, P599
[8]   Improving drug solubility for oral delivery using solid dispersions [J].
Leuner, C ;
Dressman, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :47-60
[9]   Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH [J].
Li, SF ;
Wong, SM ;
Sethia, S ;
Almoazen, H ;
Joshi, YM ;
Serajuddin, ATM .
PHARMACEUTICAL RESEARCH, 2005, 22 (04) :628-635
[10]  
NAKATANI M, 2004, Patent No. 20040110813